AlpInvest Partners

AlpInvest Partners B.V. is a private equity investment firm headquartered in Amsterdam, Netherlands, with additional offices in the United States and Asia. Founded in 1999, the firm specializes in a wide array of investment strategies, including direct investments, fund of funds, secondary investments, and co-investments. AlpInvest targets various sectors such as technology, healthcare, consumer, and industrial services, focusing on both established and emerging markets across North America, Europe, and Asia-Pacific. The firm typically allocates significant capital to private equity funds and engages in investments across the spectrum, which includes large and middle-market buyouts, growth capital, and distressed debt. AlpInvest advises sophisticated institutional investors, including pension funds and insurance companies, managing substantial client assets on a discretionary basis. With a team of over 150 professionals, AlpInvest partners with global private equity funds while actively participating in the investment process as a co-investor.

Edo Aalbers

Principal, Portfolio and Risk Analysis

Eric Anton

Managing Director, Secondary and Portfolio Finance

Jason Awad

Associate, Co-Investments

Piet-Hein den Blanken

Managing Director

Vjerana Burleigh

Managing Director, Secondary and Portfolio Finance

Joseph Chang

Principal, Primary Fund Investments

Louis Choy

Managing Director, Secondary and Portfolio Finance

Neal Costello

Managing Director

Kelly Damstra

Principal, Portfolio and Risk Analysis

Samip Dasgupta

Principal, Co-Investments

Alexander Forster

Executive Director

Mark Goldberg

Principal, Portfolio and Risk Analysis

Joeri de Groot

Managing Director

Jeff Gruccio

Principal, Primary Investments

Michael Hacker

Managing Director

Eric Hanno

Partner and Managing Director

Rob de Jong

Managing Director

Richard Kim

Investment Manager

Paul de Klerk

CFO / COO

Jorn Krenn

Principal, Secondary and Portfolio Finance

Ashwin Kroon

Vice President, Secondary Investments

Broes Langelaar

Managing Director and Co-Investments

Joe Ma

Principal, Secondary and Portfolio Finance

Mattia Manni

Investments Associate

Linda van Merrienboer

Investment Manager

Sidharth Murdeshwar

Managing Director, Co-Investments

David Pareja

Principal, Secondary and Portfolio Finance

Chris Perriello

Partner

Julian Rampelmann

Managing Director

Matthew Romanczuk

Managing Director, Secondary and Portfolio Finance

Maarten Rossum

Managing Director and Head of Portfolio and Risk Analysis

Todd Ruggini

Managing Director

Amit Sachdeva

Managing Director, Co-Investments

Bart Schuppen

Principal, Co-Investments

Jennifer Shen

Principal

Stefan Singer

Managing Director, Secondary and Portfolio Finance

Roberto Torrini

Managing Director, Co-investments

Job Wolters

Principal and Treasurer

Xu CFA, Sujaree

Vice President, Fund Investments

Wendy Zhu

Managing Partner

Linda Zhu

VP

23 past transactions

Essential Pharma Group

Private Equity Round in 2024
Essential Pharma (EP) ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers by providing medicines that otherwise would not be available.

Maison Sport

Series A in 2023
Maison Sport is a company that specializes in connecting skiers and snowboarders with qualified instructors through an online platform. Founded by three passionate ski instructors, the company simplifies the booking process, allowing customers to find and secure lessons with experienced instructors verified by sports governing bodies. By facilitating this connection, Maison Sport not only enhances the experience for those seeking to learn but also supports instructors in marketing their services. Currently operating in France, the company has plans for global expansion, aiming to bring together enthusiasts of skiing and snowboarding with skilled professionals who share their passion for the sport.

SolarWinds

Post in 2021
SolarWinds Corporation is a provider of information technology infrastructure management software, catering to both domestic and international markets. The company focuses on developing products that assist IT professionals, managed service providers, and DevOps teams in monitoring and managing their IT environments, whether they are on-premises, in the cloud, or in hybrid settings. Its offerings include network management software that provides real-time visibility into network utilization and performance, as well as application performance management tools that enable monitoring of log data, cloud metrics, and applications. SolarWinds also delivers IT service management solutions to support outsourcing of IT services and offers remote monitoring software for desktops, laptops, and servers across various platforms. Additionally, the company provides an email protection and archiving platform to safeguard against cyber threats. Founded in 1999 and headquartered in Austin, Texas, SolarWinds aims to simplify IT management challenges with purpose-built, value-driven products and tools.

Stagwell

Private Equity Round in 2018
Stagwell is working to build an investment portfolio of marketing services companies. We are putting digital first in all investments without being weighed down by legacy assets. Our portfolio will only have one or two of each kind of agency from: digital media buying to market research to public relations and beyond to allow for true cooperation. Most importantly, we know great talent needs to be valued and nurtured to achieve best in class growth that will allow for generous incentives and financial rewards. To facilitate that growth, we will act as value added investors, not simply managers, through new business development, strategic counsel and add-on acquisitions that keep agencies on the cutting edge of marketing innovation.

Hans Anders

Venture Round in 2014
Hans Anders is the N°1 optical and the N°3 hearing device retailer in the Netherlands, the N°2 optical retailer in Belgium and the N°4 optical retailer in Sweden (following the acquisition of Direkt Optik in February 2013). The group entered the French market in 2006 and is one of the fastest growing chains. Hans Anders positions itself on the affordable segment. The group has a network of 430 stores, with 250 in the Netherlands, 95 in Belgium, 45 in France and 40 in Sweden (under the Direkt Optik brand).

42 North Dental

Private Equity Round in 2014
42 North Dental is a dental support organization in New England supporting over a dozen practice brands.

Towry

Private Equity Round in 2012
Towry Holdings Limited is a wealth management firm based in Bracknell, United Kingdom, with additional offices across the country. Founded in 1968, the company specializes in providing wealth advice and investment management services to private individuals, families, and trustees. Towry focuses on essential areas of personal finance, including pensions, retirement planning, inheritance tax planning, and investment strategies. The firm's objective is to assist clients in making informed decisions about their financial futures. In 2007, Towry rebranded from its former name, Towry Law Holdings Limited, and as of August 2016, it operates as a subsidiary of Tilney Bestinvest Group Limited.

Mydentist

Private Equity Round in 2009
Mydentist is Europe's largest provider of dental care services, operating a network of over 600 dental practices across the UK. The company employs more than 3,000 clinicians and over 6,000 staff members, dedicated to delivering high-quality dental care to more than 4 million NHS and private patients. Mydentist offers a wide range of services, including orthodontic treatments, teeth straightening, teeth whitening, and skin treatments, all aimed at enhancing oral health and overall well-being. The organization is supported by a Manchester-based center and dental academy, which houses experts in marketing, finance, human resources, and IT, providing essential support to practice teams. Mydentist emphasizes the importance of clinician support, offering career development opportunities, work-life balance, and access to cutting-edge equipment and training. This commitment fosters a strong community of professionals focused on improving patient care and outcomes.

VPIsystems

Venture Round in 2005
VPIsystems (formerly VPI Virtual Photonics) develops and markets network planning software and services for the telecommunications industry in the United States and internationally. Its products include Photonic Design Automation, a solution for the modeling and optimization of photonic components and subsystems; and OnePlan, an integrated network planning system that enables communications service providers, systems integrators, and manufacturers to design, plan, and implement their transition to an IP-based network. The company serves wireline, wireless, and broadband carriers; and network equipment manufacturers and optical equipment vendors. VPIsystems, Inc. has strategic alliances with Accenture, HP, Logica, and Tech Mahindra. The company was founded as VPI Virtual Photonics, Inc. in 1997 and changed its name to VPIsystems, Inc. in July 2001. VPIsystems, Inc. is based in Holmdel, New Jersey with additional offices in Europe, Asia, and Australia.

BioXell

Series C in 2004
BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity. The idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientific career path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners.

Develogen AG

Series C in 2003
Develogen is a biology-driven drug discovery company that is engaged in the development of therapies for diabetes and obesity. The company was founded in 1995 and is based in Georgia, United States.

Getronics

Acquisition in 2003
Getronics is an information and communications technology (ICT) services group with a legacy spanning over 125 years, operating under the Getronics and Connectis brands and owned by the AURELIUS Group, based in Munich, Germany. The company employs approximately 6,000 individuals across 18 countries in Europe, Asia Pacific, and Latin America, providing a comprehensive suite of integrated ICT services for large enterprises and the public sector. Its offerings include workspace management, application management, connectivity, data center services, cloud solutions, consulting, and managed services. Getronics is recognized as a leader in the Global Workspace Alliance, which delivers consistent IT services globally through a unified point of contact and billing, serving clients across 90 countries and managing a significant number of workspace assets on-site.

VPIsystems

Series E in 2003
VPIsystems (formerly VPI Virtual Photonics) develops and markets network planning software and services for the telecommunications industry in the United States and internationally. Its products include Photonic Design Automation, a solution for the modeling and optimization of photonic components and subsystems; and OnePlan, an integrated network planning system that enables communications service providers, systems integrators, and manufacturers to design, plan, and implement their transition to an IP-based network. The company serves wireline, wireless, and broadband carriers; and network equipment manufacturers and optical equipment vendors. VPIsystems, Inc. has strategic alliances with Accenture, HP, Logica, and Tech Mahindra. The company was founded as VPI Virtual Photonics, Inc. in 1997 and changed its name to VPIsystems, Inc. in July 2001. VPIsystems, Inc. is based in Holmdel, New Jersey with additional offices in Europe, Asia, and Australia.

MediaMine

Series B in 2001
MediaMine.com is the e-commerce division of a one of the UK's longest established home entertainment product wholesale and export companies.

Dedigate

Series A in 2000
Dedigate was one of the first advanced hosting providers for complex projects in Europe. They focused on large projects where uptime was highly important, managing thousands of servers on a global scale. Their automation platform was quite novel at that time and allowed them to keep the operational team small while providing the best service level agreements.

Impress Software

Venture Round in 2000
Impress Software Solutions, Inc. specializes in developing packaged integration applications that facilitate the integration of project management and geographical information systems with SAP. Its key products include Impress for EPM, which synchronizes project-related data between SAP PM/PS and platforms like Microsoft Project or Primavera, and Impress for GIS, which connects SAP assets with GIS features to maintain accurate asset information across systems. The company offers solutions for plant turnarounds, routine maintenance, information technology, capital projects, and spatial asset management. Its clientele spans various industries, including energy and utilities, oil and gas, aerospace and defense, chemicals, and engineering and construction. Founded in 1997 and headquartered in Waltham, Massachusetts, with additional offices in Hannover, Germany, and Huizerstraatweg, the Netherlands, Impress Software Solutions operates as a subsidiary of Impress Software GmbH and has established partnerships with notable organizations such as Accenture, ESRI, Microsoft, and Primavera.

MediaMine

Venture Round in 2000
MediaMine.com is the e-commerce division of a one of the UK's longest established home entertainment product wholesale and export companies.

EpiCept

Series B in 2000
EpiCept Corporation, headquartered in Englewood Cliffs, New Jersey, with a subsidiary in Munich, Germany, specializes in developing innovative pharmaceutical products aimed at treating pain and cancer. The company employs a unique topical delivery approach for its prescription pain medications, which allows for targeted drug administration, distinguishing its products from traditional systemic or transdermal methods. EpiCept is focused on establishing partnerships for co-marketing, co-promotion, licensing, and distribution of its products, thereby enhancing its market presence. The company has implemented a robust patent strategy to protect its product portfolio, which is anticipated to possess significant market potential.

Ingenium Pharmaceuticals AG

Series A in 1999
Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.